On November 27, 2024 Novocure (NASDAQ: NVCR) reported that management will participate in two upcoming investor conferences (Press release, NovoCure, NOV 27, 2024, View Source [SID1234648693]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Evercore ISI HealthCONx Conference on Wednesday, December 4, 2024, in Coral Gables, Florida. William Doyle, Executive Chairman, will take part in a fireside chat at 2:10 p.m. ET.
Piper Sandler Healthcare Conference on Thursday, December 5, 2024, in New York City. Mr. Doyle will take part in a fireside chat at 12:00 p.m. ET.
Live audio webcasts of each presentation can be accessed from the Investor Relations page of Novocure’s website, www.novocure.com/investor-relations, and will be available for replay for at least 14 days following the event.